EURIPID Webinar on Price Developments

This year the EURIPID collaboration will organise a series of webinars to present current important developments in the field for pharmaceutical pricing & reimbursement.

The second webinar will be held on Tuesday, 21 May 2024, 1 PM, and the target group of this Webinar are (1) members of the EURIPID collaboration, (2) National Competent Authorities on Pricing and Reimbursement and Public Healthcare Payers (NCAPR), and (3) Stakeholder in the area of pharmaceutical pricing and reimbursement (patients and consumer groups, doctor and pharmacists associations, pharmaceutical industry, etc;) . The webinar serves to strengthen cooperation with public institutions and stakeholders in the field for pharmaceutical pricing and reimbursement. It aims to analyse price developments in different markets and provide guidance on how data collected in EURIPID could contribute to evidence-based decision making. Therefore at this webinar three policy brief produced under the EURIPID ACCESS grant will be presented and discussed with participants.

Due to the broad target group and expected number of participants, there will not be enough time for an open discussion, but a structured discussion. The idea of a structured discussion is to submit questions or comments in advance. All registered participants will receive the slides of the keynote 10 days prior to the webinar (11/05/2024), which allows to cluster similar questions or comments. Questions and comments should be sent to secretary.euripid@goeg.at by 20/05/2024

If you are interested we would kindly ask you to register by writing a short e-mail to secretary.euripid@goeg.at. Looking forward to see many of you at the webinar.